Literature DB >> 33511484

Acute Diallyl Disulfide Administration Prevents and Reveres Lipopolysaccharide-Induced Depression-Like Behaviors in Mice via Regulating Neuroinflammation and Oxido-Nitrosative Stress.

Xiaoyou Wei1, Yaoying Ma2, Fu Li1, Haiyan He3, Huaxing Huang4, Chao Huang2, Zhuo Chen5, Dongjian Chen5, Jinliang Chen6, Xiaomei Yuan7.   

Abstract

Neuroinflammation and oxidative stress play critical roles in pathogenesis of depression. Diallyl disulfide (DADS), an active compound in garlic oil, has been shown to exhibit obvious anti-inflammatory and anti-oxidative activities. Preliminary evidence indicates that depression is associated with high levels of pro-inflammatory cytokines and oxidative markers, suggesting that inhibition of neuroinflammatory response and oxidative stress may be beneficial for depression interruption. Here, we investigated the antidepressant effect of DADS as well as it mechanisms in a depression-like model induced by lipopolysaccharide (LPS). Similarly to imipramine (10 mg/kg), a clinical antidepressant, DADS (40 or 80 mg/kg), which was administered 1 h before LPS treatment (pre-LPS) or 1.5 h and 23.5 h after LPS treatment (post-LPS), prevented and reversed LPS (100 μg/kg)-induced increase in immobility time in the tail suspension test (TST) and forced swim test (FST) in mice. Mechanistic studies revealed that DADS pre-treatment or post-treatment at the dose of 40 and 80 mg/kg prevented and reversed (i) LPS-induced increases in interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and nitric oxide (NO) levels in the hippocampus and prefrontal cortex, (ii) LPS-induced increases in contents of malondialdehyde (MDA), a parameter reflecting high levels of oxidative stress, and (iii) LPS-induced decreases in contents of GSH, a marker reflecting weakened anti-oxidative ability, in the hippocampus and prefrontal cortex in mice. These results indicate that DADS is comparable to imipramine in effectively ameliorating LPS-induced depression-like behaviors in mice, providing a potential value for DADS in prevention and/or therapy of depression.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  depression; diallyl disulfide; lipopolysaccharide; neuroinflammation; oxidative stress

Mesh:

Substances:

Year:  2021        PMID: 33511484     DOI: 10.1007/s10753-021-01423-0

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  58 in total

Review 1.  Ketamine for treatment-resistant depression: recent developments and clinical applications.

Authors:  Jaclyn Schwartz; James W Murrough; Dan V Iosifescu
Journal:  Evid Based Ment Health       Date:  2016-04-06

Review 2.  Is depression an inflammatory disorder?

Authors:  Charles L Raison; Andrew H Miller
Journal:  Curr Psychiatry Rep       Date:  2011-12       Impact factor: 5.285

3.  Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.

Authors:  Rudolf Uher; Ole Mors; Marcella Rietschel; Aleksandra Rajewska-Rager; Ana Petrovic; Astrid Zobel; Neven Henigsberg; Julien Mendlewicz; Katherine J Aitchison; Anne Farmer; Peter McGuffin
Journal:  J Clin Psychiatry       Date:  2011-11       Impact factor: 4.384

4.  Genome-wide association scan of trait depression.

Authors:  Antonio Terracciano; Toshiko Tanaka; Angelina R Sutin; Serena Sanna; Barbara Deiana; Sandra Lai; Manuela Uda; David Schlessinger; Gonçalo R Abecasis; Luigi Ferrucci; Paul T Costa
Journal:  Biol Psychiatry       Date:  2010-08-25       Impact factor: 13.382

Review 5.  Major depression: a role for hippocampal neurogenesis?

Authors:  Margherita M Lee; Andreas Reif; Angelika G Schmitt
Journal:  Curr Top Behav Neurosci       Date:  2013

6.  Oxidative stress, inflammation and treatment response in major depression.

Authors:  Daniel Lindqvist; Firdaus S Dhabhar; S Jill James; Christina M Hough; Felipe A Jain; F Saverio Bersani; Victor I Reus; Josine E Verhoeven; Elissa S Epel; Laura Mahan; Rebecca Rosser; Owen M Wolkowitz; Synthia H Mellon
Journal:  Psychoneuroendocrinology       Date:  2016-11-30       Impact factor: 4.905

7.  Antidepressant medications and the relative risk of suicide attempt and suicide.

Authors:  S Kapur; T Mieczkowski; J J Mann
Journal:  JAMA       Date:  1992 Dec 23-30       Impact factor: 56.272

8.  Endotoxin produces a depressive-like episode in rats.

Authors:  R Yirmiya
Journal:  Brain Res       Date:  1996-03-04       Impact factor: 3.252

Review 9.  Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.

Authors:  Andrew H Miller; Vladimir Maletic; Charles L Raison
Journal:  Biol Psychiatry       Date:  2009-01-15       Impact factor: 13.382

Review 10.  Treatment strategies to improve and sustain remission in major depressive disorder.

Authors:  Madhukar H Trivedi; Ella J Daly
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

View more
  1 in total

1.  Tris(methylthio)methane produced by Mortierella hyalina affects sulfur homeostasis in Arabidopsis.

Authors:  Y-H Tseng; S Bartram; M Reichelt; S S Scholz; A K Meents; A Ludwig; A Mithöfer; R Oelmüller
Journal:  Sci Rep       Date:  2022-08-20       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.